MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway
Open Access
- 21 June 2022
- journal article
- research article
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 66 (3)
Abstract
Noncoding RNAs are important for regulation of cardiac hypertrophy. The function of MALAT1 (a long noncoding mRNA), miR-181a, and HMGB2; their contribution to cardiac hypertrophy; and the regulatory relationship between them during this process remain unknown. In the present study, we treated primary cardiomyocytes with angiotensin II (Ang II) to mimic cardiac hypertrophy. MALAT1 expression was significantly downregulated in Ang II-treated cardiomyocytes compared with control cardiomyocytes. Ang II-induced cardiac hypertrophy was suppressed by overexpression of MALAT1 and promoted by genetic knockdown of MALAT1. A dual-luciferase reporter assay demonstrated that MALAT1 acted as a sponge for miR-181a and inhibited its expression during cardiac hypertrophy. Cardiac hypertrophy was suppressed by overexpression of a miR-181a inhibitor and enhanced by overexpression of a miR-181a mimic. HMGB2 was downregulated during cardiac hypertrophy and was identified as a target of miR-181a by bioinformatics analysis and a dual-luciferase reporter assay. miR-181a overexpression decreased the mRNA and protein levels of HMGB2. Rescue experiments indicated that MALAT1 overexpression reversed the effect of miR-181a on HMGB2 expression. In summary, the results of the present study show that MALAT1 acts as a sponge for miR-181a and thereby regulates expression of HMGB2 and development of cardiac hypertrophy. The novel MALAT1/miR-181a/HMGB2 axis might play a crucial role in cardiac hypertrophy and serve as a new therapeutic target.Keywords
This publication has 57 references indexed in Scilit:
- Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failureNature Reviews Cardiology, 2015
- Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel GrowthCirculation Research, 2014
- HMGB1 Is Involved in the Protective Effect of the PPARαAgonist Fenofibrate against Cardiac HypertrophyPPAR Research, 2014
- Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failureCardiovascular Research, 2013
- Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYBPLOS Genetics, 2013
- Quantitative Analysis of the Chromatin Proteome in Disease Reveals Remodeling Principles and Identifies High Mobility Group Protein B2 as a Regulator of Hypertrophic GrowthMolecular & Cellular Proteomics, 2012
- High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcriptionBlood, 2010
- Chromatin protein HMGB2 regulates articular cartilage surface maintenance via β-catenin pathwayProceedings of the National Academy of Sciences, 2009
- Cell Cycle Regulation by MicroRNAs in Embryonic Stem CellsCancer Research, 2009
- HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene PromoterJournal of Biological Chemistry, 2002